Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Senators Raise Alarm on Paramount-Warner MergerTwenty One Capital Updates Bylaws, Removes SoftBank ReferencesEarthquake of 4.4 Magnitude Hits NaplesVitol Moves to Open Mexico Fuel TerminalUN Deputy Visits AzerbaijanSnail boosts ATM offering capacity to $3.66MImmix Biopharma reports 95% complete response rate in trialUK factory orders contract at fastest pace since 2020Novo, Lilly weight-loss pills lure patients from compounded drugsFamilies weigh moves for gender-affirming careSenators Raise Alarm on Paramount-Warner MergerTwenty One Capital Updates Bylaws, Removes SoftBank ReferencesEarthquake of 4.4 Magnitude Hits NaplesVitol Moves to Open Mexico Fuel TerminalUN Deputy Visits AzerbaijanSnail boosts ATM offering capacity to $3.66MImmix Biopharma reports 95% complete response rate in trialUK factory orders contract at fastest pace since 2020Novo, Lilly weight-loss pills lure patients from compounded drugsFamilies weigh moves for gender-affirming care
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#nexicart-2

Latest news and interesting information about nexicart-2.

Immix Biopharma reports 95% complete response rate in trial
Today / 10:24
|
364

Immix Biopharma reports 95% complete response rate in trial

Immix Biopharma's NEXICART-2 trial achieves 95% complete response rate in AL Amyloidosis patients. Promising results for CAR-T therapy NXC-201.

COMPANY →
0
...